These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 23088666)

  • 1. Nutritional factors in herpes zoster, postherpetic neuralgia, and zoster vaccination.
    Chen JY; Chang CY; Lin YS; Hu ML
    Popul Health Manag; 2012 Dec; 15(6):391-7. PubMed ID: 23088666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.
    Johnson RW
    Aging Clin Exp Res; 2009 Jun; 21(3):236-43. PubMed ID: 19571648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
    Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
    Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of efficacy and effectiveness of live attenuated zoster vaccine.
    Gabutti G; Valente N; Sulcaj N; Stefanati A
    J Prev Med Hyg; 2014 Dec; 55(4):130-6. PubMed ID: 26137786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is peptic ulcer disease a risk factor of postherpetic neuralgia in patients with herpes zoster?
    Chen JY; Chang CY; Lan KM; Sheu MJ; Lu CL; Hu ML
    Med Hypotheses; 2013 Nov; 81(5):834-8. PubMed ID: 24074834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of varicella zoster virus: chronic pain.
    Opstelten W; McElhaney J; Weinberger B; Oaklander AL; Johnson RW
    J Clin Virol; 2010 May; 48 Suppl 1():S8-13. PubMed ID: 20510265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Johnson RW; Whitton TL
    Expert Opin Pharmacother; 2004 Mar; 5(3):551-9. PubMed ID: 15013924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management.
    Christo PJ; Hobelmann G; Maine DN
    Drugs Aging; 2007; 24(1):1-19. PubMed ID: 17233544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.
    Johnson RW; Bouhassira D; Kassianos G; Leplège A; Schmader KE; Weinke T
    BMC Med; 2010 Jun; 8():37. PubMed ID: 20565946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
    Wutzler P
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against Herpes Zoster and Postherpetic Neuralgia.
    Oxman MN; Levin MJ;
    J Infect Dis; 2008 Mar; 197 Suppl 2(Suppl 2):S228-36. PubMed ID: 18419402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
    Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N
    Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention.
    Klein NP; Bartlett J; Fireman B; Marks MA; Hansen J; Lewis E; Aukes L; Saddier P
    Vaccine; 2019 Aug; 37(36):5422-5427. PubMed ID: 31301920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of herpes zoster by vaccination].
    Kofoed K; Rønholt F; Gerstoft J; Sand C
    Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination to prevent herpes zoster in older adults.
    Gnann JW
    J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
    de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
    Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.